Rubella immunity and morbidity: Impact of different vaccination programs in Finland 1979-1992

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 1, 1996, Pages 31-35

  Ukkonen, Pentti ^a,b  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; RUBELLA VACCINE;

ADOLESCENT; AGE; ARTICLE; CONGENITAL RUBELLA SYNDROME; FEMALE; FINLAND; HEALTH CARE POLICY; HUMAN; IMMUNITY; MALE; MORBIDITY; PRESCHOOL CHILD; RUBELLA; SERODIAGNOSIS; SEX DIFFERENCE; VACCINATION;

EID: 0029869595     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027146     Document Type: Article

References (26)

1. McCollum RW, Randolph MF, Byrne EB, Hilleman MR. Rubella virus vaccine (HPV-77-DE 5). Am J Dis Child 118: 186-188, 1969.
2. Plotkin SA, Farquhar JD, Katz M, Buser F. Attenuation of RA 27/3 rubella virus in WI-38 human diploid cells. Am J Dis Child 118: 178-185, 1969
3. Weibel RE, Carlson AJ, Villarejos VM, Buynak EB, McLean AA, Hilleman MR. Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus. Proc Soc Exp Biol Med 165: 323-326, 1980.
4. Preblud SR, Serdula MK, Frank JA, Brandling-Bennett AD, Hinman AR. Rubella vaccination in the United States: a ten-year review. Epidemiol Rev 2: 171-194, 1980.
5. Cutts FT, Zell ER, Mason D, Bernier RH, Dini EF, Orenstein WA. Monitonng progress toward US preschool immunization goals. JAMA 267: 1952-1955, 1992.
6. Miller CL, Miller E, Waight PA. Rubella susceptibility and the continuing risk of infection in pregnancy. Br Med J 294: 1277-1278, 1987.
7. Walker D, Carter H, Jones IG. Measles, mumps, and rubella: the need for a change in immunisation policy. Br Med J 292: 1501-1502, 1986.
8. Peltola H, Karanko V, Kurki T, Hukkanen V, Virtanen M, Penttinen K, Nissinen M, Heinonen OP. Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet 1: 137-139, 1986.
9. Paunio M, Virtanen M, Peltola H, Cantell K, Paunio P, Valle M, Karanko V, Hemonen OP. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland. Am J Epidemiol 133: 1152-1160, 1991.
10. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. N. Engl J Med 331: 1397-1402, 1994.
11. Ukkonen P, von Bonsdorff C-H. Rubella immunity and morbidity: effects of vaccination in Finland. Scand J Infect Dis 20: 255-259, 1988.
12. Ukkonen P, Hovi T, von Bonsdorff C-H, Saikku P, Penttinen K. Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: a computer analysis of 58,500 patients covering a period of eight years. J Med Virol 13: 131-148, 1984.
13. Väänänen P, Vaheri A Hemolysis-in-gel test in immunity surveys and diagnosis of rubella. J Med Virol 3: 245-252, 1979.
14. Hedman K, Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 8: 214-221, 1988.
15. Brunell PA, Weigle K, Murphy MD, Shehab Z, Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 250: 1409-1412, 1983.
16. Vesikari T, Ala-Laurila E-L, Heikkinen A, Terho A, D'Hondt E. André FE. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. Am J Dis Child 138: 843-847, 1984
17. Witte JJ, Karchmer AW, Case G, Herrmann KL, Abrutyn E, Kassanoff I, Neill JS. Epidemiology of rubella. Am J Dis Child 118: 107-111, 1969.
18. Redd SC, Wharton M, Hadler SC, Orenstein WA. The measles-mumps-rubella vaccination program in Finland. N Engl J Med 332: 1102-1103, 1995.
19. Munro ND, Wild NJ, Sheppard S, Smithells RW, Hambling MH. Fall and rise of immunity to rubella. Br Med J 294: 481, 1987.
20. Miller E. The new measles campaign. Br Med J 309: 1102-1103, 1994.
21. Christenson B, Böttiger M, Heller L. Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience. Br Med J 287: 389-391, 1983.
22. Carter H, Gorman D. Measles, mumps, and rubella vaccine: time for a two stage policy? Br Med J 304: 637, 1992.
23. Anderson RM, May RM. Immunisation and herd immunity. Lancet 1. 641-645, 1990.
24. Babad HR, Nokes DJ, Gay NJ, Miller E, Morgan-Capner P, Anderson RM. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect 114: 319-344, 1995.
25. Nohynek H, Pekkanen E, Eskola J (eds). The vaccinator's Manual (in Finnish). Helsinki: Kustannus Oy Duodecim, 1993.
26. Huygelen C, Sigel MM, Zygraich N, Peetermans JH, Colinet G, Leyten R, Raupp WG, Pinto CA, Garg SG, Boyle JJ, Haff, RF. Safety testing of rubella virus vaccine (Cendehill strain). Am J Dis Child 118. 362-366, 1969.